Cargando…
Transport of the multidrug resistance modulators verapamil and azidopine in wild type and daunorubicin resistant Ehrlich ascites tumour cells.
Verapamil has been proposed to modulate the multidrug resistance phenotype by competitive inhibition of an energy dependent efflux of cytotoxic drug. However, the accumulation of both 14C-verapamil and 3H-verapamil was similar in wild type EHR2 and multidrug resistant EHR2/DNR+ Ehrlich ascites cells...
Autores principales: | Sehested, M., Skovsgaard, T., Jensen, P. B., Demant, E. J., Friche, E., Bindslev, N. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971743/ https://www.ncbi.nlm.nih.gov/pubmed/1975202 |
Ejemplares similares
-
Inhibition of vincristine binding to plasma membrane vesicles from daunorubicin-resistant Ehrlich ascites cells by multidrug resistance modulators.
por: Sehested, M., et al.
Publicado: (1989) -
Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells.
por: Friche, E., et al.
Publicado: (1993) -
Increased plasma membrane traffic in daunorubicin resistant P388 leukaemic cells. Effect of daunorubicin and verapamil.
por: Sehested, M., et al.
Publicado: (1987) -
P-glycoprotein expression in Ehrlich ascites tumour cells after in vitro and in vivo selection with daunorubicin.
por: Nielsen, D., et al.
Publicado: (1998) -
Cyclosporin A corrects daunorubicin resistance in Ehrlich ascites carcinoma.
por: Slater, L. M., et al.
Publicado: (1986)